NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. SIGNIFICANT ACCOUNTING POLICIES
Business
Key Tronic Corporation and subsidiaries (the Company) is engaged in electronic manufacturing services (EMS) for original equipment manufacturers (OEMs) and also manufactures keyboards and other input devices. The Company’s headquarters are located in Spokane Valley, Washington with manufacturing operations in Oakdale, Minnesota; Fayetteville, Arkansas; Corinth, Mississippi; and foreign manufacturing operations in Juarez, Mexico; Shanghai, China; and Da Nang, Vietnam.
The 2019 novel strain of coronavirus ("COVID-19") has resulted in business slowdowns or shutdowns in affected areas. In January 2020, the Company’s China facilities faced temporary shutdowns as a result of government mandates. In March 2020, these facilities began returning to full operation and the supply chain disruptions have been abating. In April 2020, the Company announced the temporary closure of its Juarez facilities, however, operations successfully resumed six days later.
Due to the COVID-19 pandemic, the Company has seen extreme shifts in demand from its customer base. The possibility of future temporary closures, as well as adverse fluctuations in customer demand, freight and expedite costs, precautionary safety expenses, collectibility of accounts, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results. Additionally, continued adverse macroeconomic conditions and significant currency exchange fluctuations can also materially impact operating results.
Reclassifications
Certain prior period reclassifications were made to conform with the current period presentation. These reclassifications had no effect on reported income, comprehensive income, cash flows, total assets, or shareholders’ equity as previously reported.
Principles of Consolidation
The consolidated financial statements include the Company and its wholly owned subsidiaries in the United States, Mexico, China and Vietnam. Intercompany balances and transactions have been eliminated during consolidation.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Estimates include the allowance for doubtful receivables, the provision for obsolete and non-saleable inventories, deferred tax assets and liabilities, uncertain tax positions, valuation of goodwill, impairment of long-lived assets, medical self-funded insurance liability, long-term incentive compensation accrual, the provision for warranty costs, the fair value of stock appreciation rights granted under the Company’s share-based compensation plan and purchase price allocation of acquired businesses. Due to uncertainties with respect to the assumptions and estimates, actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers investments with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company may have cash and cash equivalents at financial institutions that are in excess of federally insured limits from time to time.
Allowance for Doubtful Accounts
The Company evaluates the collectability of accounts receivable and records an allowance for doubtful accounts, which reduces the receivables to an amount that management reasonably estimates will be collected. A specific allowance is recorded against receivables considered to be impaired based on the Company’s knowledge of the financial condition of the customer. In determining the amount of the allowance, the Company considers several factors including the aging of the receivables, the current business environment and historical experience. After all attempts to collect a receivable have failed, the receivable is written off against the allowance.
Inventories
Inventories are stated at the lower of cost or net realizable value. Inventory valuation is determined using the first-in, first-out (FIFO) method. Customer orders are based upon forecasted quantities of product manufactured for shipment over defined periods. Raw material inventories are purchased to fulfill these customer requirements. Within these arrangements, customer demands for products frequently change, sometimes creating excess and obsolete inventories. The Company regularly reviews raw material inventories by customer for both excess and obsolete quantities. Wherever possible, the Company attempts to recover its full cost of excess and obsolete inventories from customers or, in some cases, through other markets. When it is determined that the Company’s carrying cost of such excess and obsolete inventories cannot be recovered in full, a charge is taken against income for the difference between the carrying cost and the estimated realizable amount. We also reserve for inventory related to specific customers covered by lead-time assurance agreements when those customers are experiencing financial difficulties or reimbursement is not reasonably assured.
Property, Plant and Equipment
Property, plant and equipment are carried at cost and depreciated using straight-line methods over the expected useful lives of the assets. Repairs and maintenance costs are expensed as incurred.
Impairment of Goodwill
In accordance with accounting guidance on goodwill and other intangible assets, the Company evaluates goodwill for impairment at the reporting unit level annually, and whenever circumstances occur indicating that goodwill might be impaired. Upon adoption of ASU 2017-04, the Company now recognizes an impairment charge (not to exceed the total amount of goodwill allocated to the reporting unit) for the amount by which the carrying amount of a reporting unit exceeds the reporting unit’s fair value. During the third quarter of fiscal year 2019, a few large programs declined in revenue and two new programs were delayed. This decrease in the Company’s total revenue combined with book value continuing to exceed market capitalization caused a “triggering event” in which to perform a quantitative impairment analysis as of March 30, 2019. To estimate the fair value of the Company’s equity, the Company used both a market approach and an income approach, based on a discounted cash flows analysis. As of March 30, 2019, market related factors increased expected required rates of return, which also increased the Company’s discount rate used to project future cash flows. Further, push outs of the Company’s forecasted future cash flows relating to delays in customer orders adversely impacted the Company’s discounted cash flows model. As a result, a lower estimate in the Company’s fair value using these two valuation methods indicated an impairment charge.
During the third quarter of fiscal year 2019, the Company also assessed other finite-lived intangible assets including the Company’s customer relationships and favorable lease agreements due to an indicator of possible impairment being present, as discussed above. As a result of the analysis performed, the Company determined that the carrying value of the customer relationships intangible asset was not recoverable and recorded an impairment for the entire carrying amount during the third quarter of fiscal year 2019. The Company’s analysis did not indicate that any of its other long-lived assets were impaired. Refer to footnote 14 for impairment analysis for goodwill and other intangibles that occurred during fiscal year 2019, as a result of certain triggering events being present.
Impairment of Long-lived Assets
The Company, using its best estimates based on reasonable and supportable assumptions and projections, reviews assets for impairment whenever events or changes in circumstances have indicated that the carrying amount of its assets might not be recoverable. Impaired assets are reported at the lower of cost or fair value.
Accrued Warranty
An accrual is made for expected warranty costs, with the related expense recognized in cost of goods sold. Management reviews the adequacy of this accrual quarterly based on historical analyses and anticipated product returns.
Self-funded Insurance
The Company self-funds its domestic employee health plans. The Company contracts with a separate administrative service company to supervise and administer the programs and act as its representative. The Company reduces its risk under this self-funded platform by purchasing stop-loss insurance coverage for high dollar individual claims. In addition, if the aggregate annual claims amount to more than 125 percent of expected claims for the plan year this insurance will also pay those claims amounts exceeding that level.
The Company estimates its exposure for claims incurred but not paid at the end of each reporting period and uses historical claims data supplied by the Company’s broker to estimate its self-funded insurance liability. This liability is subject to a total limitation that varies based on employee enrollment and factors that are established at each annual contract renewal. Actual claims experience may differ from the Company’s estimates. Costs related to the administration of the plan and related claims are expensed as incurred.
Revenue Recognition
Prior to the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606), sales revenue from manufacturing is recognized upon shipment of the manufactured product per contractual terms. Upon shipment, title transfers and the customer assumes risks and rewards of ownership of the product. The price to the buyer is fixed or determinable and recoverability is reasonably assured. Unless specifically stated in contractual terms, there are no formal customer acceptance requirements or further obligations related to the manufacturing services; if any such requirements exist, then sales revenue is recognized at the time when such requirements are completed and such obligations are fulfilled. Revenue is recorded net of estimated returns of manufactured product based on management’s analysis of historical returns.
Subsequent to the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606) during the year ended June 29, 2019, the first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates.
The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed.
Shipping and Handling Fees
The Company classifies costs associated with shipping and handling fees as a component of cost of goods sold. Customer billings related to shipping and handling fees are reported as revenue.
Research, Development and Engineering
Research, development and engineering expenses include unreimbursed EMS costs as well as design and engineering costs associated with the production of EMS programs. Research, development and engineering costs are expensed as incurred.
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.
We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax provision. To date, we have not incurred charges for interest or penalties in relation to the underpayment of income taxes. The tax years 1997 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject. Refer to Note 6 for further discussions.
Derivative Instruments and Hedging Activities
The Company has entered into foreign currency forward contracts and an interest rate swap which are accounted for as cash flow hedges in accordance with ASC 815, Derivatives and Hedging. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.
The Company uses derivatives to manage the variability of foreign currency fluctuations of expenses in our Mexico facilities. The foreign currency forward contracts and interest rate swaps have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded.
The Company’s foreign currency forward contracts and interest rate swaps potentially expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the agreement. The Company minimizes such risk by seeking high quality counterparties. The Company’s counterparties to the foreign currency forward contracts and interest rate swaps are major banking institutions. These institutions do not require collateral for the contracts, and the Company believes that the risk of the counterparties failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.
Earnings Per Common Share
Basic earnings per common share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per common share is computed by dividing net income by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of stock options were used to repurchase common shares at the average market price during the period. The computation of diluted earnings per common share does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on earnings per share.
Foreign Currency Transactions
The functional currency of the Company’s subsidiaries in Mexico and China is the U.S. dollar. Realized foreign currency transaction gains and losses for local currency denominated assets and liabilities are included in cost of goods sold.
Fair Value of Financial Instruments
The carrying values of cash and cash equivalents, accounts receivable, current liabilities, and non current operating lease liability are reflected on the balance sheets at June 27, 2020 and June 29, 2019, reasonably approximate their fair value. The Company had an outstanding balance on the line of credit of $60.1 million as of June 27, 2020 and $23.4 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value. The Company had an outstanding balance on the term loan of $10.0 million as of June 27, 2020 and $11.3 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value. The equipment term loan is estimated to be $0.9 million as of June 27, 2020 and $1.7 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value.
Share-based Compensation
The Company’s incentive plan may provide for equity and liability awards to employees in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is included in cost of goods sold, research, development and engineering, and selling, general, and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.
Newly Adopted and Recent Accounting Pronouncements
In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), which modifies certain provisions of ASC 740, Income Taxes, in an effort to reduce the complexity of accounting for income taxes. ASU 2019-12 is effective for us the first quarter of fiscal year 2022. We are currently evaluating the effects and do not believe this standard will have a material impact on our consolidated financial position, results of operations, or cash flows.
In June 2018, the FASB issued ASU 2018-07 "Compensation - Stock Compensation (Topic 718): Improvement to Nonemployee Share-Based Payment Accounting" with the objective of simplifying several aspects of the accounting for nonemployee share-based payment transactions in current GAAP. The Company adopted this guidance during the first quarter of fiscal year 2020 with an immaterial impact on its consolidated financial statements.
In August 2017, the FASB issued ASU 2017-12 "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities" with the objective of improving the financial reporting of hedging relationships and simplifying the application of the hedge accounting guidance in current GAAP. The Company adopted this guidance during the first quarter of fiscal year 2020 with no impact on its consolidated financial statements.
In February 2016, the FASB issued Accounting Standards Update ASU 2016-02, Leases which supersedes ASC 840 Leases and creates a new topic, ASC 842 Leases. This update requires lessees to recognize a lease asset and a lease liability for all leases, including operating leases, with a term greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures surrounding leases.
The Company adopted ASC 842 on June 30, 2019 using the modified retrospective method for leases existing at June 30, 2019. As a result, the Company was not required to adjust its comparative period financial information for effects of the standard or make the new required lease disclosures for periods before our adoption date. Management elected the package of practical expedients which, among other things, allows the Company to carry forward historical lease classification in place prior to June 30, 2019. ASC 842 also provides practical expedients for an entity’s accounting after transition. Management has elected the short-term lease recognition exemption for all leases that qualify, as well as the practical expedient to not separate lease and non-lease components. Both of these expedients were elected for all classes of underlying leased assets. As the Company cannot determine the interest rate implicit in the lease for its leases, the Company uses its estimate of the incremental borrowing rate as of the commencement date in determining the present value of lease payments. The Company’s estimated incremental borrowing rate is the rate of interest it would have to pay on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment. The lease term for all of the Company’s leases includes the noncancellable period of the lease plus any additional periods covered by either an option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise.
The adoption of ASC 842 had a material impact to the Company’s consolidated balance sheet, but did not materially impact the consolidated statement of income or consolidated statement of cash flows. The most significant changes to the consolidated balance sheet relate to the recognition of new right-of-use (ROU) assets and lease liabilities for operating leases.
As a result of adopting ASC 842 as of June 30, 2019, the Company recognized an ROU asset of $21.4 million, a corresponding lease liability of $20.4 million, a reduction in prepaid rent of $0.4 million, a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact.
In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing the impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024.
The Company adopted Accounting Standards Update 2014-09 (ASU 2014-09), Revenue from Contracts with Customers (Topic 606) (also referred to as Accounting Standard Codification 606 (“ASC 606”) on July 1, 2018 using the modified retrospective approach by applying the guidance to all open contracts at the adoption date and has implemented revised accounting policies, new operational and financial reporting processes, enhanced systems capabilities and relevant internal controls. As part of adopting ASC 606, revenue for certain customer contracts where the Company is manufacturing products for which there is no alternative use and the Company has an enforceable right to payment including a reasonable profit for work-in-progress inventory will be recognized over time instead of upon shipment of products.
The cumulative effect of change made to our July 1, 2018 consolidated balance sheet for the adoption of ASC 606 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Balance Sheet
|
Impact of Adopting ASC 606
|
|
|
(Unaudited, in thousands)
|
Balance at June 30, 2018
|
Adjustments
|
Balance at July 1, 2018
|
ASSETS
|
|
|
|
Contract assets
|
—
|
|
11,906
|
|
11,906
|
|
Inventories
|
110,315
|
|
(11,210)
|
|
99,105
|
|
Deferred income tax asset
|
7,882
|
|
(167)
|
|
7,715
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
Retained earnings
|
72,806
|
|
529
|
|
73,335
|
|
The following tables summarize the impacts of ASC 606 adoption on the Company’s consolidated balance sheets and consolidated statements of income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Balance Sheet
|
|
|
|
As of June 29, 2019
|
Impact of Adopting ASC 606
|
|
|
(Unaudited, in thousands)
|
As Reported
|
606 Adjustment
|
Balance without 606 Adoption
|
ASSETS
|
|
|
|
Contract assets
|
22,161
|
|
(22,161)
|
|
—
|
|
Inventories
|
100,431
|
|
19,563
|
|
119,994
|
|
Deferred income tax asset
|
7,840
|
|
167
|
|
8,007
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
Retained earnings
|
65,353
|
|
2,431
|
|
62,922
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Statement of Income (Loss)
|
|
|
|
|
Impact of Adopting ASC 606
|
|
|
(Unaudited, in thousands)
|
Twelve Months Ended June 29, 2019
|
|
|
|
As Reported
|
606 Adjustment
|
Balance without 606 Adoption
|
Net sales
|
$
|
464,044
|
|
$
|
10,254
|
|
$
|
453,790
|
|
Cost of sales
|
$
|
429,443
|
|
$
|
8,353
|
|
$
|
421,090
|
|
Gross profit
|
$
|
34,601
|
|
$
|
1,901
|
|
$
|
32,700
|
|
Net income
|
$
|
(7,982)
|
|
$
|
1,901
|
|
$
|
(9,883)
|
|
For the fiscal year ended June 29, 2019, the reported revenue and gross profit was approximately $464.0 million, and $34.6 million; respectively. This reflects the adoption of ASC 606 as revenue and gross profit would have been $10.3 million and $1.9 million less without ASC 606 adoption; respectively. This is primarily due to the change from 'point-in-time' to 'over-time' recognition as the standard requires. There was not a material tax impact for the twelve months ended June 29, 2019 from adopting ASC 606.
Fiscal Year
The Company operates on a 52/53 week fiscal year. Fiscal years end on the Saturday nearest June 30. As such, fiscal years 2020, 2019, and 2018, ended on June 27, 2020, June 29, 2019, and June 30, 2018, respectively. Fiscal year 2020, 2019 and 2018 were all 52 week years.
2. INVENTORIES
The components of inventories consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 27, 2020
|
|
June 29, 2019
|
Finished goods
|
$
|
15,269
|
|
|
$
|
11,969
|
|
Work-in-process
|
17,390
|
|
|
11,705
|
|
Raw materials and supplies
|
82,361
|
|
|
76,757
|
|
|
$
|
115,020
|
|
|
$
|
100,431
|
|
Total inventory as of June 27, 2020 is net of $17.3 million of reserves, customer payments, and customer deposits compared to $10.8 million in reserves, customer payments, and customer deposits as of June 29, 2019.
3. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life
|
|
June 27, 2020
|
|
June 29, 2019
|
|
(in years)
|
|
(in thousands)
|
|
|
Land
|
—
|
|
$
|
4,034
|
|
|
$
|
2,940
|
|
Buildings and improvements
|
3 to 30
|
|
23,444
|
|
|
23,776
|
|
Equipment
|
1 to 10
|
|
72,151
|
|
|
67,348
|
|
Furniture and fixtures
|
3 to 5
|
|
4,883
|
|
|
4,248
|
|
Total Property, Plant and Equipment
|
|
|
104,512
|
|
|
98,312
|
|
Accumulated depreciation
|
|
|
(72,748)
|
|
|
(68,899)
|
|
Property, Plant and Equipment, net
|
|
|
$
|
31,764
|
|
|
$
|
29,413
|
|
4. LONG-TERM DEBT
On March 5, 2020, the Company entered into a Seventh amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $65.0 million. Outside of the limit increase of the credit facility, the agreement reflects the same specifications and terms as the sixth amendment to the amended and restated credit agreement entered into by the Company on November 20, 2019; discussed below. As of June 27, 2020, the Company had an outstanding balance under the credit facility of $60.1 million, $0.4 million in outstanding letters of credit and $4.5 million available for future borrowings. As of June 29, 2019, the Company had an outstanding balance under the credit facility of $23.4 million, $0.4 million in outstanding letters of credit and $21.3 million available for future borrowings. The Company's debt was paid in full in conjunction with the closing of a new credit facility subsequent to June 27, 2020. Refer to footnote 17 - Subsequent Events for additional details.
On November 20, 2019, the Company entered into a Sixth amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $55.0 million as evidenced by the Second Replacement Revolving Note. The agreement specifies that the proceeds of the revolving line of credit be used primarily for working capital and general corporate purposes. The line of credit is secured by substantially all of the assets of the Company. On September 30, 2018, the Company entered into a Fourth amendment to the amended and restated credit agreement to extend the maturity date to November 1, 2023, at which time all outstanding balances are payable.
On September 10, 2019, the Company entered into a Fifth amendment to the amended and restated credit agreement to increase the outstanding balance on the term loan in the amount of $5.0 million and to extend the maturity date to September 30, 2022 on the original term loan in the amount of $35.0 million that was used to acquire all of the outstanding shares of CDR Manufacturing, Inc. (dba Ayrshire Electronics). The term loan requires quarterly payments of $1.67 million commencing December 31, 2019 through September 30, 2021, and quarterly payments of $0.4 million commencing December 31, 2021 through September 30, 2022, with a final payment of the remaining outstanding balance on September 30, 2022. The Company had an outstanding balance of $10.0 million and $11.3 million under the term loan as of June 27, 2020 and June 29, 2019, respectively.
On December 28, 2016, the Company entered into an equipment term loan agreement in the amount of $3.9 million in order to further invest in production equipment. The equipment term loan is collateralized by production equipment. Under this loan agreement, equal quarterly payments of approximately $0.2 million commenced on March 31, 2017 and will continue through the maturity of the equipment term loan on June 30, 2021. Amortization of the debt issuance costs is reported as interest expense on the consolidated income statement. As of June 27, 2020, the Company had an outstanding balance of $0.9 million. As of June 29, 2019, the Company had an outstanding balance of $1.7 million.
The Fifth amendment to the amended and restated credit agreement noted above to increase the outstanding balance on the term loan in the amount of $5.0 million fixes borrowings under the revolving line of credit, term loan and equipment term loan to bear interest at LIBOR plus 2.0%, as opposed to previous borrowings at either a “Base Rate” or a “Fixed Rate,” as elected by the Company. The base rate is the higher of the Wells Fargo Bank prime rate, daily one month London Interbank Offered Rate (LIBOR) plus 1.5%, or the Federal Funds rate plus 1.5%. The fixed rate is LIBOR plus 1.75%, LIBOR plus 2.0% or LIBOR plus 2.25% depending on the level of the Company’s trailing four quarters Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). The interest rates on the outstanding debt as of June 27, 2020 range from 2.17% - 2.18% compared to 4.40% - 5.50% as of June 29, 2019.
Debt maturities as of June 27, 2020 for the next four years are as follows (in thousands):
|
|
|
|
|
|
Fiscal Years Ending
|
Amount
|
2021
|
$
|
7,537
|
|
2022
|
2,917
|
|
2023
|
417
|
|
2024
|
60,094
|
|
|
|
Total debt
|
$
|
70,965
|
|
Unamortized debt issuance costs
|
(30)
|
|
Long-term debt, net of debt issuance costs
|
$
|
70,935
|
|
The Company must comply with certain financial covenants, including a cash flow leverage ratio, an asset coverage ratio and a fixed charge coverage ratio. The credit agreement requires the Company to maintain a minimum profit threshold, limits the maximum capital lease expenditures and restricts the Company from declaring or paying dividends in cash or stock without prior bank approval. The Company was in compliance with all financial covenants as of June 27, 2020.
5. TRADE ACCOUNTS RECEIVABLE PURCHASE PROGRAMS
Sale Programs
The Company has utilized an Account Purchase Agreement with Wells Fargo Bank, N.A. ("WFB") which allows the Company to sell and assign to WFB and WFB may purchase from Company the accounts receivable of certain Company customers in a maximum aggregate amount outstanding of $25.0 million. This agreement may be cancelled at any time by either party. The Company also has an Account Purchase Agreement with Orbian Financial Services (“Orbian”). This agreement allows the Company to sell accounts receivable of certain customers to Orbian and the agreement may be cancelled at any time by either party.
Total accounts receivables sold during the twelve months ended June 27, 2020 and June 29, 2019 was approximately $41.4 million and $81.0 million, respectively. Accounts receivables sold and not yet collected was approximately $9,000 and $1.7 million as of June 27, 2020 and June 29, 2019, respectively. The receivables that were sold were removed from the consolidated balance sheets and the cash received is reflected as cash provided by operating activities in the consolidated statements of cash flows. The Company no longer had factored receivables at year end fiscal 2020.
6. INCOME TAXES
Income tax benefit consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended
|
|
|
|
|
|
June 27, 2020
|
|
June 29, 2019
|
|
June 30, 2018
|
|
(in thousands)
|
|
|
|
|
Current income tax benefit:
|
|
|
|
|
|
United States
|
$
|
365
|
|
|
$
|
(537)
|
|
|
$
|
(221)
|
|
Foreign
|
154
|
|
|
895
|
|
|
1,722
|
|
|
519
|
|
|
358
|
|
|
1,501
|
|
Deferred income tax benefit:
|
|
|
|
|
|
United States
|
(1,850)
|
|
|
(910)
|
|
|
(795)
|
|
Foreign
|
892
|
|
|
(206)
|
|
|
(823)
|
|
|
(958)
|
|
|
(1,116)
|
|
|
(1,618)
|
|
Total income tax benefit
|
$
|
(439)
|
|
|
$
|
(758)
|
|
|
$
|
(117)
|
|
The Company has gross tax credit carryforwards of approximately $8.8 million at June 27, 2020 consisting of federal research and development (R&D) tax credits.
Management has reviewed all deferred tax assets for purposes of determining whether or not a valuation allowance may be required. A valuation allowance against deferred tax assets is required if it is more likely than not that some of the deferred tax assets will not be realized. Based upon the Company’s profitability, forecasted income, and evaluation of all other positive and negative evidence, management determined that it is more likely than not that the deferred tax assets will be realized.
Subsequent to the end of the fiscal year ending June 27, 2020, the Treasury Department issued final regulations applicable to the Company’s position with respect to the U.S. taxability of foreign earnings under the global intangible low taxed income (also known as “GILTI”) regime and the deductibility of interest expense under IRC Section 163(j). The Company is still evaluating the impact of these regulations, and, at this time, it does not anticipate any material impact to its current or future income tax positions.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits net operating loss (NOL) carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company does not expect that the NOL carryback provision of the CARES Act will result in a material cash benefit. In addition, the CARES Act contains modifications on the limitation of business interest for tax years beginning in 2019 and 2020. The modifications to Section 163(j) increase the allowable business interest deduction from 30% of adjusted taxable income to 50% of adjusted taxable income. This modification would increase the allowable interest expense deduction of the Company and result in less taxable income for fiscal year 2020, but is not expected to have a material impact on the provision for income taxes. Also, under the CARES Act, AMT credits not previously refunded for the 2018 tax year are refundable in the 2019 taxable year rather than in years 2019-2021, and taxpayers can elect to claim 100% of the AMT credits in the first taxable year beginning in 2018 by applying for a tentative refund claim on or before December 31, 2020. The Company has made this election by applying for a tentative refund claim. The Company is taking advantage of the deferred payment payroll taxes provision, the impacts of which are not expected to be material. The Company is continuing to evaluate the impacts of other aspects of the CARES Act, and at this time the Company does not believe they will have a material impact on our consolidated financial position, results of operations, or cash flows.
On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. The Tax Act reduced Federal corporate tax rates effective January 1, 2018, and changed certain other provisions, many of which were not effective until fiscal year 2019. Effective tax rates for fiscal year 2018, were blended rates reflecting the benefit of two quarters of Federal tax rate reductions. These benefits were offset by discrete expenses relating to the revaluation of our U.S. net deferred tax assets, an adjustment relating to foreign exchange, and required adjustments associated with the transition from a global to a territorial tax system (discussed further below).
As a result of the U.S. tax system under the Tax Act from a global to a territorial model, a deemed one-time repatriation of all accumulated earnings and profits (AE&P) in Mexico and China occurred on December 31, 2017 (the “Transition Tax”).
On December 22, 2017, the staff of the SEC issued Staff Accounting Bulletin No. 118 (“SAB No. 118”). SAB No. 118 provided guidance on accounting for the tax effects of the 2017 Tax Act and allowed registrants to record provisional amounts for a period of up to one year from the date of enactment of the 2017 Tax Act. In fiscal year 2019, we finalized the Transition Tax calculation, resulting in a net Transition Tax amount of $0.8 million, a decrease of $0.4 million for the fiscal year.
In addition to the $0.8 million Transition Tax described above, the Company recognized a $1.3 million discrete expense in fiscal year 2018 due to the revaluation of our U.S. net deferred tax assets. Offsetting these amounts, because of the shift to a territorial system of taxation in the U.S., the Company recognized a discrete benefit of approximately $1.3 million related to reversing its previously recognized estimated liability associated with estimated future repatriations from Mexico and China.
In future years, because of the Transition Tax on AE&P described above, repatriations of cash will generally be tax-free in the U.S. However, withholding taxes in China may still apply to any such future repatriations. Management has not changed its indefinite investment assertions with regards to the portion of AE&P in China that may be repatriated in the future. Accordingly, management estimates that future repatriations of cash from China may result in approximately $0.8 million of withholding tax. There would be no offsetting foreign tax credits in the U.S. and as such, this potential liability is a direct cost associated with actual repatriations. Withholding taxes will not apply to future repatriations from Mexico or Vietnam.
The Company expects to repatriate a portion of its foreign earnings based on increased net sales growth driving additional capital requirements domestically, cash requirements for potential acquisitions and to implement certain tax strategies. The Company expects to repatriate approximately $7.8 million from China, in the future. All other unremitted foreign earnings are expected to remain permanently reinvested for planned fixed assets purchases and improvements in foreign locations.
The Company’s effective tax rate differs from the federal tax rate as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended
|
|
|
|
|
|
June 27, 2020
|
|
June 29, 2019
|
|
June 30, 2018
|
|
(in thousands)
|
|
|
|
|
Federal income tax provision (benefit) at statutory rates
|
$
|
907
|
|
|
$
|
(1,836)
|
|
|
$
|
(397)
|
|
State income taxes, net of federal tax effect
|
90
|
|
|
(158)
|
|
|
(4)
|
|
Foreign tax rate differences
|
336
|
|
|
251
|
|
|
103
|
|
Tax rate change
|
—
|
|
|
—
|
|
|
1,634
|
|
Provisional transition tax on accumulated foreign earnings
|
—
|
|
|
(384)
|
|
|
1,190
|
|
Effect of income tax credits
|
(310)
|
|
|
(861)
|
|
|
(687)
|
|
Previously unrecognized tax benefits
|
(1,345)
|
|
|
—
|
|
|
—
|
|
Effect of repatriation of foreign earnings, net
|
—
|
|
|
(42)
|
|
|
(1,484)
|
|
Goodwill write-off
|
—
|
|
|
1,726
|
|
|
—
|
|
Global Intangible Low-Taxed Income (GILTI) tax
|
—
|
|
|
150
|
|
|
—
|
|
Provision to return reconciliation
|
(241)
|
|
|
630
|
|
|
(401)
|
|
Other
|
124
|
|
|
(234)
|
|
|
(71)
|
|
Income tax benefit
|
$
|
(439)
|
|
|
$
|
(758)
|
|
|
$
|
(117)
|
|
The domestic and foreign components of income (loss) before income taxes were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended
|
|
|
|
|
|
June 27, 2020
|
|
June 29, 2019
|
|
June 30, 2018
|
|
(in thousands)
|
|
|
|
|
Domestic
|
$
|
1,142
|
|
|
$
|
(12,220)
|
|
|
$
|
(4,593)
|
|
Foreign
|
3,177
|
|
|
3,480
|
|
|
3,151
|
|
Income (loss) before income taxes
|
$
|
4,319
|
|
|
$
|
(8,740)
|
|
|
$
|
(1,442)
|
|
Deferred income tax assets and liabilities consist of the following at:
|
|
|
|
|
|
|
|
|
|
|
|
|
June 27, 2020
|
|
June 29, 2019
|
|
(in thousands)
|
|
|
Deferred tax assets:
|
|
|
|
Net operating loss
|
$
|
184
|
|
|
$
|
33
|
|
Tax credit carryforwards, net
|
5,961
|
|
|
4,986
|
|
Inventory
|
1,426
|
|
|
1,087
|
|
Identifiable intangibles
|
493
|
|
|
407
|
|
Interest expense carryforward
|
—
|
|
|
474
|
|
Accruals
|
2,847
|
|
|
3,549
|
|
Research and development expenses
|
—
|
|
|
232
|
|
Mart-to-market adjustments
|
415
|
|
|
—
|
|
ASC 606 deferred costs
|
1,943
|
|
|
2,484
|
|
Lease liabilities
|
3,201
|
|
|
—
|
|
Other
|
212
|
|
|
30
|
|
Deferred income tax assets
|
$
|
16,682
|
|
|
$
|
13,282
|
|
Deferred tax liabilities:
|
|
|
|
Accrued withholding tax - unremitted earnings
|
(820)
|
|
|
(820)
|
|
Fixed assets
|
(566)
|
|
|
(443)
|
|
Right-of-use assets
|
(3,290)
|
|
|
—
|
|
Mart-to-market adjustments
|
—
|
|
|
(730)
|
|
ASC 606 accelerated revenue
|
(1,344)
|
|
|
(3,274)
|
|
|
|
|
|
Other
|
(718)
|
|
|
(175)
|
|
Deferred income tax liabilities
|
$
|
(6,738)
|
|
|
$
|
(5,442)
|
|
Net deferred income tax assets
|
$
|
9,944
|
|
|
$
|
7,840
|
|
Balance sheet caption reported in:
|
|
|
|
Long-term deferred income tax asset
|
$
|
10,178
|
|
|
$
|
7,840
|
|
Long-term deferred income tax liability
|
(234)
|
|
|
—
|
|
|
|
|
|
Net deferred income tax asset
|
$
|
9,944
|
|
|
$
|
7,840
|
|
Certain reclassifications have been made in the 2019 information in the above table to conform with 2020 presentation.
Uncertain Tax Positions:
The Company has R&D tax credits that approximate $8.8 million that have 20-year carryforwards before expiring. The Company’s R&D tax credits expire in various fiscal years from 2026 to 2040. The Company also has alternative minimum tax credits, which do not expire, approximating $347,000, which are now classified as a receivable due to the repeal of the alternative minimum tax.
As of June 27, 2020, the Company had unrecognized tax benefits of $2.9 million related to its gross R&D tax credits. The unrecognized tax benefits relate to certain R&D tax credits generated from 2002 to 2020.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended
|
|
|
|
|
|
June 27, 2020
|
|
June 29, 2019
|
|
June 30, 2018
|
|
(in thousands)
|
|
|
|
|
Beginning Balance
|
$
|
4,099
|
|
|
$
|
4,011
|
|
|
$
|
3,947
|
|
Additions based on tax positions related to the current year
|
109
|
|
|
88
|
|
|
64
|
|
Lapse of statute of limitations
|
(1,345)
|
|
|
—
|
|
|
—
|
|
Ending Balance
|
$
|
2,863
|
|
|
$
|
4,099
|
|
|
$
|
4,011
|
|
The increase from the prior year is due to additional R&D credits that were recorded in 2020 as discussed above. Management does not anticipate any material changes to this amount during the next 12 months.
The Company recognizes interest accrued related to unrecognized tax benefits and penalties in its income tax provision. The Company has not recognized any interest or penalties in the fiscal years presented in these financial statements. The Company is subject to income tax in the U.S. federal jurisdiction, various state jurisdictions, Mexico, China and Vietnam. Certain years remain subject to examination but there are currently no ongoing exams in any taxing jurisdictions.
7. EARNINGS PER SHARE
Basic earnings per share (EPS) is calculated by dividing net income (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted EPS is computed by including both the weighted-average number of shares outstanding and any dilutive common share equivalents in the denominator. The following table presents a reconciliation of the denominator and the number of antidilutive common share awards that were not included in the diluted earnings per share calculation. These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended
(in thousands, except per share information)
|
|
|
|
|
|
June 27, 2020
|
|
June 29, 2019
|
|
June 30, 2018
|
Net income (loss)
|
$
|
4,758
|
|
|
$
|
(7,982)
|
|
|
$
|
(1,325)
|
|
Weighted average shares outstanding– basic
|
10,760
|
|
|
10,760
|
|
|
10,760
|
|
Effect of dilutive common stock awards
|
57
|
|
|
—
|
|
|
—
|
|
Weighted average shares outstanding – diluted
|
10,816
|
|
|
10,760
|
|
|
10,760
|
|
Net income (loss) per share – basic
|
$
|
0.44
|
|
|
$
|
(0.74)
|
|
|
$
|
(0.12)
|
|
Net income (loss) per share – diluted
|
$
|
0.44
|
|
|
$
|
(0.74)
|
|
|
$
|
(0.12)
|
|
Antidilutive SARs not included in diluted earnings per share
|
720
|
|
|
985
|
|
|
827
|
|
8. STOCK OPTION AND BENEFIT PLANS
The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.
In addition to service conditions, these SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are measured over the vesting period and are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant and expire five years from date of grant.
On July 26, 2019, the Company granted 175,000 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $4.93 and a grant date fair value of $1.23. As of June 27, 2020, 150,000 remain outstanding. The grant date fair value for the awards granted during fiscal year 2020, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 26, 2019:
|
|
|
|
|
|
|
Fiscal Year 2020
|
|
July 26, 2019
|
Expected dividend yield
|
—%
|
Risk – free interest rate
|
1.54%
|
Expected volatility
|
28.50%
|
Expected life
|
4.00
|
On July 27, 2018, the Company granted 161,250 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $8.17 and a grant date fair value of $2.27. As of June 27, 2020, 121,250 remain outstanding. The grant date fair value for the awards granted during fiscal year 2019, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 27, 2018:
|
|
|
|
|
|
|
Fiscal Year 2019
|
|
July 27, 2018
|
Expected dividend yield
|
—%
|
Risk – free interest rate
|
2.80%
|
Expected volatility
|
29.75%
|
Expected life
|
4.00
|
On July 28, 2017, the Company granted 272,500 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $7.26 and a grant date fair value of $1.89. As of June 27, 2020, 197,500 remain outstanding. The grant date fair value for the awards granted during fiscal year 2018, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 28, 2017:
|
|
|
|
|
|
|
Fiscal Year 2018
|
|
July 28, 2017
|
Expected dividend yield
|
—%
|
Risk – free interest rate
|
1.70%
|
Expected volatility
|
29.76%
|
Expected life
|
4.00
|
Subsequent to June 27, 2020, the Company granted 155,000 SARs with a strike price of $6.94 and a grant date fair value of $2.32.
Share-based compensation expense is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on the Company’s historical experience and future expectations. This forfeiture rate will be revised, if necessary, in subsequent periods if actual forfeitures differ from the amount estimated. Share-based compensation expense for fiscal years ended June 27, 2020, June 29, 2019 and June 30, 2018 was $0.3 million, $0.4 million and $0.4 million, respectively.
The Black-Scholes option valuation model is used by the Company for estimating the fair value of SARs. Option valuation models require the input of highly subjective assumptions, particularly for the expected term and expected stock price volatility. Changes in these assumptions can materially affect the fair value estimates.
There were no SARs exercised during fiscal year 2020, 2019 or 2018.
As of June 27, 2020, total unrecognized compensation expense related to nonvested share-based compensation arrangements was approximately $0.2 million. This expense is expected to be recognized over a weighted-average period of 1.58 years.
The following table summarizes the Company’s Options and SARs activity for all plans from July 2, 2016 through June 27, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SARs
Available
For Grant
|
|
SARs
Outstanding
|
|
Aggregate
Intrinsic
Value (in
thousands)
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Contractual
Life (in
years)
|
Balances, July 1, 2017
|
394,335
|
|
|
1,084,999
|
|
|
$
|
—
|
|
|
$
|
9.09
|
|
|
2.3
|
Shares authorized
|
—
|
|
|
|
|
|
|
—
|
|
|
|
SARs granted
|
(272,500)
|
|
|
272,500
|
|
|
|
|
7.26
|
|
|
|
SARs forfeited
|
282,500
|
|
|
(282,500)
|
|
|
|
|
7.84
|
|
|
|
SARs exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Balances June 30, 2018
|
404,335
|
|
|
1,074,999
|
|
|
$
|
79
|
|
|
$
|
8.90
|
|
|
2.3
|
Shares authorized
|
—
|
|
|
|
|
|
|
—
|
|
|
|
SARs granted
|
(161,250)
|
|
|
161,250
|
|
|
|
|
8.17
|
|
|
|
SARs forfeited
|
250,833
|
|
|
(250,833)
|
|
|
|
|
10.59
|
|
|
|
SARs exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Balances, June 29, 2019
|
493,918
|
|
|
985,416
|
|
|
$
|
—
|
|
|
$
|
8.35
|
|
|
1.7
|
Shares authorized
|
—
|
|
|
|
|
|
|
—
|
|
|
|
SARs granted
|
(175,000)
|
|
|
175,000
|
|
|
|
|
4.93
|
|
|
|
SARs forfeited
|
290,833
|
|
|
(290,833)
|
|
|
|
|
7.71
|
|
|
|
SARs exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Balances, June 27, 2020
|
609,751
|
|
|
869,583
|
|
|
$
|
—
|
|
|
$
|
7.87
|
|
|
1.9
|
Exercisable at June 27, 2020
|
|
|
400,833
|
|
|
$
|
—
|
|
|
$
|
9.18
|
|
|
0.6
|
Additional information regarding SARs outstanding and exercisable as of June 27, 2020, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range of
Exercise Prices
|
|
Number Outstanding
|
|
Weighted Avg.
Remaining
Contractual Life (yrs.)
|
|
Weighted Avg.
Exercise Price
|
|
Number
Exercisable
|
|
Weighted
Avg. Exercise
Price
|
$4.40 – $7.90
|
|
347,500
|
|
|
2.1
|
|
$
|
6.25
|
|
|
—
|
|
|
$
|
—
|
|
7.91 – 9.91
|
|
328,750
|
|
|
0.6
|
|
8.17
|
|
|
207,500
|
|
|
8.17
|
|
9.92 – 11.34
|
|
193,333
|
|
|
0.1
|
|
10.26
|
|
|
193,333
|
|
|
10.26
|
|
$4.40 to $11.34
|
|
869,583
|
|
|
1.9
|
|
$
|
7.87
|
|
|
400,833
|
|
|
$
|
9.18
|
|
The Company has defined contribution plans available to U.S. employees who have attained age 21. Company contributions to the plans were approximately $0.8 million, $0.9 million, and $0.8 million during fiscal years 2020, 2019 and 2018, respectively.
9. COMMITMENTS AND CONTINGENCIES
Leases: As of June 27, 2020, June 29, 2019 and June 30, 2018, the Company did not have any property and equipment financed under capital leases. Please refer to Note 16 for information regarding operating lease commitments.
Rental expense under operating leases was approximately $4.2 million, $5.0 million, and $7.1 million during fiscal years 2020, 2019 and 2018, respectively.
Warranty Costs: The Company provides warranties on certain product sales, and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. The Company establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior twelve months’ sales activities. As of June 27, 2020 and June 29, 2019, the reserve for warranty costs was approximately $15,000 and $22,000, respectively.
If actual return rates and/or repair and replacement costs differ significantly from estimates, adjustments to recognize additional cost of sales may be required in future periods. Warranty expense for fiscal years 2020, 2019 and 2018 was related to workmanship claims on certain EMS products.
Litigation: The Company is party to certain lawsuits or claims in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the financial position, results of operations or cash flow of the Company.
Indemnification Rights: Under the Company’s bylaws, the Company’s directors and officers have certain rights to indemnification by the Company against certain liabilities that may arise by reason of their status or service as directors or officers. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and officers and former directors in certain circumstances.
10. DERIVATIVE FINANCIAL INSTRUMENTS
As of June 27, 2020, the Company had outstanding foreign currency forward contracts and swaps with a total notional amount of $36.7 million. The maturity dates for these contracts and swaps extend through December 2021. As of June 27, 2020, the net amount of unrealized loss expected to be reclassified into earnings within the next 12 months is approximately $1.8 million. During the fiscal year ended June 27, 2020, the Company entered into $23.8 million of foreign currency forward contracts and settled $26.7 million of such contracts. During the fiscal year ended June 29, 2019, the Company entered into $19.2 million of foreign currency forward contracts and settled $25.9 million of such contracts. During the fiscal year ended June 30, 2018, the Company entered into $13.7 million of foreign currency forward contracts and settled $28.1 million of such contracts.
As of June 27, 2020, the aggregate notional amount of the Company’s outstanding foreign currency contracts and swaps along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ending
|
|
Notional Contracts and Swaps in MXN
|
|
Notional Contracts and Swaps in USD
|
|
Estimated Fair Value
|
September 26, 2020
|
|
$
|
141,173
|
|
|
$
|
6,729
|
|
|
$
|
(623)
|
|
December 26, 2020
|
|
$
|
132,773
|
|
|
$
|
6,241
|
|
|
$
|
(561)
|
|
April 3, 2021
|
|
$
|
148,253
|
|
|
$
|
6,682
|
|
|
$
|
(425)
|
|
July 3, 2021
|
|
$
|
144,725
|
|
|
$
|
6,446
|
|
|
$
|
(367)
|
|
October 2, 2021
|
|
$
|
146,373
|
|
|
$
|
5,502
|
|
|
$
|
564
|
|
January 1, 2022
|
|
$
|
137,973
|
|
|
$
|
5,129
|
|
|
$
|
532
|
|
On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, with a notional amount of $15.0 million related to the borrowings outstanding under the term loan. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.70% that replaces the one month LIBOR rate component of our contractual interest to be paid to WFB as part of our term loan. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the term loan, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. As of June 27, 2020, the remaining notional balance of this swap was $11.7 million.
On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, with a notional amount of $15.0 million related to the borrowings outstanding under the line of credit. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.67% that replaces the one month LIBOR rate component of our contractual interest to be paid to WFB as part of our line of credit. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the line of credit, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. In conjunction with the new credit facility, the interest rate swap contracts have been terminated. Please refer to footnote 17 Subsequent Event for more information.
The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheets as of June 27, 2020 and June 29, 2019 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 27, 2020
|
|
June 29, 2019
|
Derivatives Designated as Hedging Instruments
|
|
Balance Sheet Location
|
|
Fair Value
|
|
Fair Value
|
Foreign currency forward contracts & swaps
|
|
Other current assets
|
|
$
|
—
|
|
|
$
|
2,912
|
|
Foreign currency forward contracts & swaps
|
|
Other long-term assets
|
|
$
|
1,097
|
|
|
$
|
320
|
|
Foreign currency forward contracts & swaps
|
|
Other current liabilities
|
|
$
|
(1,960)
|
|
|
$
|
—
|
|
Foreign currency forward contracts & swaps
|
|
Other long-term liabilities
|
|
$
|
(17)
|
|
|
$
|
—
|
|
Interest rate swaps
|
|
Other current assets
|
|
$
|
—
|
|
|
$
|
2
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
Other current liabilities
|
|
$
|
(347)
|
|
|
$
|
—
|
|
Interest rate swaps
|
|
Other long-term liabilities
|
|
$
|
(610)
|
|
|
$
|
—
|
|
The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2020 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives Designated as Hedging Instruments
|
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
|
|
AOCI Balance
as of
June 29, 2019
|
|
Effective
Portion
Recorded In
AOCI
|
|
Effective Portion
Reclassified From
AOCI Into Income
|
|
AOCI Balance
as of
June 27, 2020
|
Forward contracts & swaps
|
Cost of sales
|
|
$
|
2,424
|
|
|
$
|
(865)
|
|
|
$
|
(2,318)
|
|
|
$
|
(759)
|
|
Interest rate swap
|
Interest expense
|
|
2
|
|
|
(782)
|
|
|
39
|
|
|
(741)
|
|
Total
|
|
|
$
|
2,426
|
|
|
$
|
(1,647)
|
|
|
$
|
(2,279)
|
|
|
$
|
(1,500)
|
|
The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2019 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives Designated as Hedging Instruments
|
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
|
|
AOCI Balance
as of
June 30, 2018
|
|
Effective
Portion
Recorded In
AOCI
|
|
Effective Portion
Reclassified From
AOCI Into Income
|
|
AOCI Balance
as of
June 29, 2019
|
Forward contracts & swaps
|
Cost of sales
|
|
$
|
(988)
|
|
|
$
|
3,332
|
|
|
$
|
80
|
|
|
$
|
2,424
|
|
Interest rate swap
|
Interest expense
|
|
19
|
|
|
2
|
|
|
(19)
|
|
|
2
|
|
Total
|
|
|
$
|
(969)
|
|
|
$
|
3,334
|
|
|
$
|
61
|
|
|
$
|
2,426
|
|
The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2018 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives Designated as Hedging Instruments
|
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
|
|
AOCI Balance
as of
July 1, 2017
|
|
Effective
Portion
Recorded In
AOCI
|
|
Tax Rate Effect Reclassification
|
|
Effective Portion
Reclassified From
AOCI Into Income
|
|
AOCI Balance
as of
June 30, 2018
|
Forward contracts & swaps
|
Cost of sales
|
|
$
|
(2,707)
|
|
|
$
|
(1,942)
|
|
|
$
|
(583)
|
|
|
$
|
4,244
|
|
|
$
|
(988)
|
|
Interest rate swap
|
Interest expense
|
|
(68)
|
|
|
20
|
|
|
(3)
|
|
|
70
|
|
|
19
|
|
Total
|
|
|
$
|
(2,775)
|
|
|
$
|
(1,922)
|
|
|
$
|
(586)
|
|
|
$
|
4,314
|
|
|
$
|
(969)
|
|
As of June 27, 2020, the Company does not have any foreign exchange contracts with credit-risk-related contingent features. The Company is subject to the risk of fluctuating interest rates from our line of credit and foreign currency risk resulting from our China operations. The Company does not currently manage these risk exposures by using derivative instruments.
11. FAIR VALUE MEASUREMENTS
The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and expands disclosures about fair value measurements. There are three levels of fair value hierarchy inputs used to value assets and liabilities which include: Level 1 – inputs are quoted market prices for identical assets or liabilities; Level 2 – inputs other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – inputs are unobservable inputs for the asset or liability. There have been no changes in the fair value methodologies used at June 27, 2020 and June 29, 2019.
The following table summarizes the fair value of assets (liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of June 27, 2020 and June 29, 2019 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 27, 2020
|
|
|
|
|
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
Fair Value
|
Financial Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts & swaps
|
$
|
—
|
|
|
$
|
1,097
|
|
|
$
|
—
|
|
|
$
|
1,097
|
|
Financial Liabilities:
|
|
|
|
|
|
|
|
Interest rate swaps
|
$
|
—
|
|
|
$
|
(957)
|
|
|
$
|
—
|
|
|
$
|
(957)
|
|
Foreign currency forward contracts & swaps
|
$
|
—
|
|
|
$
|
(1,977)
|
|
|
$
|
—
|
|
|
$
|
(1,977)
|
|
|
|
|
|
|
|
|
|
|
June 29, 2019
|
|
|
|
|
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
Fair Value
|
Financial Assets:
|
|
|
|
|
|
|
|
Interest rate swaps
|
$
|
—
|
|
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
2
|
|
Foreign currency forward contracts & swaps
|
—
|
|
|
3,232
|
|
|
—
|
|
|
$
|
3,232
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company currently has forward contracts to hedge known future cash outflows for expenses denominated in the Mexican peso and an interest rate swap to mitigate risk associated with certain borrowings under the Company’s debt arrangement. These contracts are measured on a recurring basis based on the foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. These contracts are marked to market using level 2 input criteria every quarter with the unrealized gain or loss, net of tax, reported as a component of shareholders’ equity in accumulated other comprehensive income (loss), as they qualify for hedge accounting.
The carrying values of cash and cash equivalents, accounts receivable, current liabilities, and non current lease liability are reflected on the balance sheets at June 27, 2020 and June 29, 2019, reasonably approximate their fair value.
The Company’s long-term debt, which is measured at amortized cost, primarily consists of a revolving line of credit, a term loan and an equipment term loan. These borrowings bear interest at either a “Base Rate” or a “Fixed Rate,” as elected by the Company. Each of these rates is a variable floating rate dependent upon current market conditions and the Company’s current credit risk as discussed in footnote 4.
As a result of the determinable market rate for our revolving line of credit, term loan and equipment term, they are classified within Level 2 of the fair value hierarchy. Further, the carrying value of each of these instruments reasonably approximates their fair value as of June 27, 2020 and June 29, 2019.
Other assets and liabilities held by the Company may be required to be measured at fair value on a non recurring basis. As of June 29, 2019, the customer relationship intangibles were written down to their fair value of $0. This measurement was the result of certain triggering events that occurred during the third quarter of fiscal year 2019. Refer to Note 14 for further discussion of the impairment.
12. ENTERPRISE-WIDE DISCLOSURES
Operating segments are defined in ASC Topic 280, Segment Reporting as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. As of June 27, 2020, the Company operates and internally manages a single operating segment, Electronics Manufacturing Services as this is the only discrete financial information that is regularly reviewed by the chief operating decision maker. This segment provides integrated electronic and mechanical engineering, assembly, sourcing and procurement, logistics, and new product testing for our customers.
Products and Services
Of the revenues for the years ended June 27, 2020, June 29, 2019, and June 30, 2018, EMS sales and services were $449.5 million, $463.9 million and $445.8 million, respectively. Keyboard sales for the years ended June 27, 2020, June 29, 2019, and June 30, 2018 were $4,000, $0.1 million and $0.5 million, respectively.
Geographic Areas
Net sales and long-lived assets (property, plant, and equipment) by geographic area for the years ended and as of June 27, 2020, June 29, 2019 and June 30, 2018 are summarized in the following table. Net sales set forth below are based on the shipping destination. Long-lived assets information is based on the physical location of the asset.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended
|
|
|
|
|
|
(in thousands)
|
|
|
|
|
|
2020
|
|
2019
|
|
2018
|
Geographic net sales:
|
|
|
|
|
|
Domestic (U.S.)
|
$
|
338,766
|
|
|
$
|
357,341
|
|
|
$
|
329,230
|
|
Foreign
|
110,714
|
|
|
106,703
|
|
|
117,092
|
|
Total
|
$
|
449,480
|
|
|
$
|
464,044
|
|
|
$
|
446,322
|
|
|
|
|
|
|
|
Long-lived assets:
|
|
|
|
|
|
United States
|
$
|
9,213
|
|
|
$
|
9,658
|
|
|
$
|
7,454
|
|
Mexico
|
19,325
|
|
|
17,781
|
|
|
19,395
|
|
Vietnam
|
2,644
|
|
|
1,220
|
|
|
—
|
|
China
|
582
|
|
|
754
|
|
|
699
|
|
Total
|
$
|
31,764
|
|
|
$
|
29,413
|
|
|
$
|
27,548
|
|
Percentage of net sales made to customers located in the following countries:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended
|
|
|
|
|
|
2020
|
|
2019
|
|
2018
|
United States
|
75%
|
|
77%
|
|
74%
|
China
|
19
|
|
19
|
|
24
|
Other foreign countries (a)
|
5
|
|
3
|
|
2
|
Canada
|
1
|
|
1
|
|
—
|
Total
|
100%
|
|
100%
|
|
100%
|
(a) No other individual foreign country accounted for 10% or more of the foreign sales in fiscal years 2020, 2019 or 2018.
Significant Customers
The percentage of net sales to and trade accounts receivables from significant customers were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of Net
Sales Fiscal Year
|
|
|
|
|
|
Percentage of
Trade Accounts Receivable
Fiscal Year
|
|
|
|
2020
|
|
2019
|
|
2018
|
|
2020
|
|
2019
|
Customer A
|
18%
|
|
17%
|
|
19%
|
|
14%
|
|
11%
|
Customer B
|
*
|
|
*
|
|
*
|
|
12 %
|
|
*
|
|
|
|
|
|
|
|
|
|
|
* Current customer amount represents less than 10%.
13. QUARTERLY FINANCIAL DATA (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended June 27, 2020
|
|
|
|
|
|
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
(in thousands, except per share amounts)
|
|
|
|
|
|
|
Net sales
|
$
|
105,285
|
|
|
$
|
116,722
|
|
|
$
|
111,455
|
|
|
$
|
116,018
|
|
Gross profit
|
9,273
|
|
|
8,122
|
|
|
9,248
|
|
|
8,606
|
|
Income before income taxes
|
1,829
|
|
|
974
|
|
|
1,010
|
|
|
506
|
|
Net income
|
1,552
|
|
|
824
|
|
|
910
|
|
|
1,472
|
|
Net income per share - basic
|
$
|
0.14
|
|
|
$
|
0.08
|
|
|
$
|
0.08
|
|
|
$
|
0.14
|
|
Net income per share - diluted
|
$
|
0.14
|
|
|
$
|
0.08
|
|
|
$
|
0.08
|
|
|
$
|
0.14
|
|
Weighted average shares outstanding
|
|
|
|
|
|
|
|
Basic
|
10,760
|
|
|
10,760
|
|
|
10,760
|
|
|
10,760
|
|
Diluted
|
10,805
|
|
|
10,877
|
|
|
10,885
|
|
|
10,832
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended June 29, 2019
|
|
|
|
|
|
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
(in thousands, except per share amounts)
|
|
|
|
|
|
|
Net sales
|
$
|
127,472
|
|
|
$
|
123,037
|
|
|
$
|
107,954
|
|
|
$
|
105,581
|
|
Gross profit
|
9,533
|
|
|
9,880
|
|
|
6,807
|
|
|
8,381
|
|
Income (loss) before income taxes
|
1,868
|
|
|
1,916
|
|
|
(13,256)
|
|
|
732
|
|
Net income (loss)
|
1,593
|
|
|
1,589
|
|
|
(11,981)
|
|
|
817
|
|
Net income (loss) per share - basic
|
$
|
0.15
|
|
|
$
|
0.15
|
|
|
$
|
(1.11)
|
|
|
$
|
0.08
|
|
Net income (loss) per share - diluted
|
$
|
0.15
|
|
|
$
|
0.15
|
|
|
$
|
(1.11)
|
|
|
$
|
0.08
|
|
Weighted average shares outstanding
|
|
|
|
|
|
|
|
Basic
|
10,760
|
|
|
10,760
|
|
|
10,760
|
|
|
10,760
|
|
Diluted
|
10,979
|
|
|
10,881
|
|
|
10,760
|
|
|
10,760
|
|
14. GOODWILL AND OTHER INTANGIBLE ASSETS
The Company recorded goodwill in connection with the Ayrshire and Sabre acquisitions resulting primarily from the synergies that resulted from the Company's acquisitions and the assembled workforce. The goodwill is not amortized for financial accounting purposes.
In accordance with accounting guidance on goodwill and other intangible assets, the Company evaluates goodwill for impairment at the reporting unit level annually, and whenever circumstances occur indicating that goodwill might be impaired. Upon adoption of ASU 2017-04, the Company now recognizes an impairment charge (not to exceed the total amount of goodwill allocated to the reporting unit) for the amount by which the carrying amount of a reporting unit exceeds the reporting unit’s fair value. During the third quarter of fiscal year 2019, a goodwill impairment of $10.0 million was recognized.
During the third quarter for fiscal year 2019, the Company assessed other finite-lived intangible assets including the Company’s customer relationships and favorable lease agreements due to an indicator of possible impairment being present. As a result of the analysis performed, the Company determined that the carrying value of the customer relationships intangible asset was not recoverable and recorded an impairment for the entire carrying amount during the third quarter of fiscal year 2019. This resulted in an impairment charge related to other intangible assets of $2.5 million recognized in the third quarter of fiscal year 2019. The Company’s analysis did not indicate that any of its other long-lived assets were impaired.
During the first quarter of fiscal year 2020, the Company adopted the Accounting Standards Update 2016-02, Leases which supersedes ASC 840 Leases and creates a new topic, ASC 842 Leases. Under ASC 842, any assets or liabilities recognized in accordance with ASC 805 that are related to favorable or unfavorable terms of an operating lease for which an entity is a lessee, the entity should derecognize the asset or liability and commensurately adjust the ROU asset. Refer to footnote 16 for additional disclosure.
As such, the Company derecognized the intangible asset and added the offsetting amount to the ROU asset. Resulting in a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact.
The components of acquired intangible assets are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 27, 2020
|
|
|
|
|
|
|
|
|
|
Amortization Period
in Years
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
|
Derecognition Favorable Lease per ASC 842
|
|
Net Carrying
Amount
|
Other intangible assets:
|
|
|
|
|
|
|
|
|
|
Favorable Lease Agreements
|
4 - 7
|
|
2,941
|
|
|
(2,284)
|
|
|
(657)
|
|
|
—
|
|
Total
|
|
|
$
|
2,941
|
|
|
$
|
(2,284)
|
|
|
$
|
(657)
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 29, 2019
|
|
|
|
|
|
|
|
|
|
Amortization Period
in Years
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
|
Impairment
Recognized
|
|
Net Carrying
Amount
|
Other intangible assets:
|
|
|
|
|
|
|
|
|
|
Non-Compete Agreements
|
3 - 5
|
|
$
|
568
|
|
|
$
|
(568)
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Customer Relationships
|
10
|
|
4,803
|
|
|
(2,311)
|
|
|
(2,492)
|
|
|
—
|
|
Favorable Lease Agreements
|
4 - 7
|
|
2,941
|
|
|
(2,284)
|
|
|
—
|
|
|
657
|
|
Total
|
|
|
$
|
8,312
|
|
|
$
|
(5,163)
|
|
|
$
|
(2,492)
|
|
|
$
|
657
|
|
Amortization expense related to intangible assets was approximately $0.6 million and $1.1 million for the year ended June 29, 2019, and June 30, 2018; respectively.
15. REVENUE
Revenue Recognition
The Company specializes in services ranging from product manufacturing to engineering and tooling services. The first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates.
The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed.
The Company’s typical payment terms are 30 to 45 days and its sales arrangements do not contain any significant financing component for its customers.
The Company generally provides a warranty for workmanship on its manufacturing contracts. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s warranties.
The Company elected to not disclose information about remaining performance obligations as they are part of contracts that that have expected durations of one year or less.
The Company has elected to expense costs to obtain contracts as incurred as these costs are immaterial to the financial statements.
During fiscal 2020, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods.
Contract Balances
A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice for payment. Contract assets are classified separately on the condensed consolidated balance sheet and transferred to receivables when the right to payment becomes unconditional.
The following table summarizes the activity in the Company’s contract assets during the twelve months ended June 27, 2020 (in thousands):
|
|
|
|
|
|
|
Contract Assets
|
Beginning balance, June 29, 2019
|
$
|
22,161
|
|
Revenue recognized
|
441,405
|
|
Amounts collected or invoiced
|
(439,813)
|
|
Ending balance, June 27, 2020
|
$
|
23,753
|
|
The following table summarizes the activity in the Company’s contract assets during the twelve months ended June 29, 2019 (in thousands):
|
|
|
|
|
|
|
Contract Assets
|
Beginning balance, June 30, 2018
|
—
|
|
Cumulative effect adjustment at July 1, 2018
|
11,906
|
|
Revenue recognized
|
448,003
|
|
Amounts collected or invoiced
|
(437,748)
|
|
Ending balance, June 29, 2019
|
$
|
22,161
|
|
Disaggregation of Revenue
The following table presents the Company’s revenue disaggregated for the twelve months ended June 27, 2020 and the twelve months ended June 29, 21019 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
Recognition
|
|
June 27, 2020
|
|
June 29, 2019
|
Over-Time
|
|
$
|
441,405
|
|
|
$
|
458,256
|
|
Point-in-Time
|
|
8,075
|
|
|
5,788
|
|
Total
|
|
$
|
449,480
|
|
|
$
|
464,044
|
|
Revenues and associated costs from engineering design, development services and tooling, which are performed under contract of short term durations, are recognized over time as the services are performed. Revenue from engineering design, development
services and tooling represented approximately 3.3% of total revenue in fiscal year 2020.
16. LEASES
The Company has several commitments under operating leases for warehouses, manufacturing facilities, office buildings, and equipment with initial terms that expire at various dates during the next 1 year to 11 years.
The Company has some operating leases that include an extension clause. Management has considered the likelihood of exercising each extension option included and estimated the duration of the extension option, for those leases management determined to be reasonably certain, in calculating the lease term for measurement of the right of use asset and liability.
For operating leases, management assumed a discount rate of 4% - 5.9%. The weighted average discount rate is disclosed in the tables below.
The components of lease cost as of June 27, 2020 were (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
Lease cost
|
Classification
|
June 27, 2020
|
Operating lease cost
|
Cost of sales
|
$
|
4,511
|
|
Operating lease cost
|
Selling, general and administrative expenses
|
1,266
|
|
Total lease cost
|
|
$
|
5,777
|
|
Amounts reported in the Consolidated Balance Sheet as of June 27, 2020 were (in thousands, except weighted average lease term and discount rate):
|
|
|
|
|
|
|
|
|
|
|
June 27, 2020
|
Operating Leases:
|
|
|
Operating lease right of use assets
|
|
$
|
17,568
|
|
Operating lease liabilities (1)
|
|
17,173
|
|
|
|
|
Weighted-average remaining lease term (in years)
|
|
|
Operating leases
|
|
6.46
|
|
|
|
Weighted-average discount rate
|
|
|
Operating leases
|
|
4.07
|
%
|
(1) The current portion of the total operating lease liabilities of $4.5 million is classified under Other Current Liabilities, resulting in $12.6 million classified under Operating Lease Liabilities in the Long-term Liabilities section of the consolidated balance sheet.
Other information related to leases was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 27, 2020
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|
Operating cash flows from operating leases
|
|
4,237
|
|
The Company entered into one new lease during the fiscal year, resulting in a non-cash impact of $0.4 million.
Future lease payments under non-cancellable leases as of June 27, 2020 are as follows (in thousands):
|
|
|
|
|
|
|
|
|
Fiscal Years Ending
|
|
Operating Leases
|
2021
|
|
$
|
4,250
|
|
2022
|
|
3,373
|
|
2023
|
|
2,598
|
|
2024
|
|
2,004
|
|
2025
|
|
1,894
|
|
Thereafter
|
|
5,674
|
|
Total undiscounted lease payments
|
|
19,793
|
|
Less: present value discount
|
|
2,620
|
|
Total lease liabilities
|
|
$
|
17,173
|
|
As previously disclosed in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019 and under the previous lease accounting standard ASC 840, the aggregate future minimum payments under non-cancellable operating leases, as of June 29, 2019, are as follows (in thousands):
|
|
|
|
|
|
|
|
|
Fiscal Years Ending
|
|
Operating Leases
|
2020
|
|
$
|
4,777
|
|
2021
|
|
3,563
|
|
2022
|
|
2,641
|
|
2023
|
|
1,866
|
|
2024
|
|
1,271
|
|
Thereafter
|
|
4,121
|
|
Total minimum lease payments
|
|
$
|
18,239
|
|
The Company identified certain immaterial errors in relation to its computation of its operating lease right-of-use assets and operating lease liabilities upon adoption of ASC 842, which primarily related to the improper exclusion of fixed rent escalation clauses. The errors were considered to be immaterial to previously issued quarterly reports on Form 10-Q as of September 28, 2019, December 28, 2019 and March 28, 2020. The impact of the correction on the respective balance sheets was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 28, 2019
|
|
|
|
Amounts as reported
|
Adjustments
|
Amounts as corrected
|
Operating lease right-of-use assets, net
|
$
|
16,056
|
|
$
|
4,223
|
|
$
|
20,279
|
|
Total assets
|
$
|
281,127
|
|
$
|
4,223
|
|
$
|
285,350
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating lease liabilities - Long-term
|
$
|
10,885
|
|
$
|
4,223
|
|
$
|
15,108
|
|
Total Liabilities
|
$
|
165,989
|
|
$
|
4,223
|
|
$
|
170,212
|
|
|
|
|
|
|
December 28, 2019
|
|
|
|
Amounts as reported
|
Adjustments
|
Amounts as corrected
|
Operating lease right-of-use assets, net
|
$
|
14,876
|
|
$
|
4,223
|
|
$
|
19,099
|
|
Total assets
|
$
|
273,970
|
|
$
|
4,223
|
|
$
|
278,193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating lease liabilities - Long-term
|
$
|
9,870
|
|
$
|
4,223
|
|
$
|
14,093
|
|
Total Liabilities
|
$
|
157,163
|
|
$
|
4,223
|
|
$
|
161,386
|
|
|
|
|
|
|
March 28, 2020
|
|
|
|
Amounts as reported
|
Adjustments
|
Amounts as corrected
|
Operating lease right-of-use assets, net
|
$
|
15,347
|
|
$
|
3,127
|
|
$
|
18,474
|
|
Total assets
|
$
|
288,403
|
|
$
|
3,127
|
|
$
|
291,530
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating lease liabilities - Long-term
|
$
|
10,327
|
|
$
|
3,127
|
|
$
|
13,454
|
|
Total Liabilities
|
$
|
175,463
|
|
$
|
3,127
|
|
$
|
178,590
|
|
17. SUBSEQUENT EVENT
On August 14, 2020, the Company entered into a loan and security agreement (the “Loan Agreement”) with Bank of America. The Loan Agreement replaces the Company’s prior amended and restated credit agreement, as amended, with Wells Fargo Bank, N.A. The Loan Agreement provides for a five-year asset-based senior secured revolving credit facility of up to $93 million, maturing on August 14, 2025. In addition, during the term of the Loan Agreement, the Company may increase the aggregate amount of the Credit Facility by up to an additional $25 million, subject to customary conditions, including obtaining a commitment from the Bank (or another lender, if applicable) to such increase.
The Credit Facility has been used to pay-off the Prior Credit Facility and costs related to the Loan Agreement, and may be used to pay-off certain other existing debt, to issue letters of credit, and for other business purposes, including working capital needs. Based on the Company’s borrowing base and reserve requirements and after paying off the Prior Credit Facility and related fees and expenses relating to the Credit Facility, immediately following the closing of the Loan Agreement, there was approximately $16 million available under the Credit Facility.
The Loan Agreement contains financial covenants as long as commitments or obligations are outstanding under the Loan Agreement, requiring the Company to maintain: (i) a fixed charge coverage ratio of at least 1.25 to 1.0, measured monthly on a trailing 12-month basis; and (ii) a cash flow leverage ratio of no greater than 6.00 to 1.00, which may be subject to adjustments for COVID-19 related cash expenses as approved by the Bank, measured monthly on a trailing 12-month basis.